Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

EACS: Predictors of HCV Viral Load in HIV/HCV Coinfected Patients

Editor's pick
HIVandhepatitis.com
27 October 2011
Hepatitis C treatment

EACS: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People

Editor's pick
HIVandhepatitis.com
20 October 2011
Adherence

Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
AIDSMeds
13 October 2011
Adherence

Copy of Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
Kaiser Daily Global Health Policy Report
13 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
Hepatitis C treatment

Updated Hepatitis C Practice Guidelines Now Available from AASLD

Editor's pick
Market Watch (press release)
28 September 2011
New & experimental hepatitis C treatment

Treatment Action Group publishes Guide to Clinical Trials for People With Hepatitis C

Editor's pick
Treatment Action Group
17 August 2011
Adherence

Injection Drug Users and Adherence to Hepatitis C Treatment

Editor's pick
HIV & Hepatitis
1 August 2011
Hepatitis C transmission & prevention

Hepatitis Scotland launched to tackle viral hepatitis

Editor's pick
Scottish Drugs Forum
29 June 2011
New & experimental hepatitis C treatment

Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment

Editor's pick
The Body
3 June 2011
Hepatitis C treatment

The Fair Pricing Coalition Expresses Disappointment at the Price of Vertex’s Newly Approved Hepatitis C Drug

Editor's pick
Fair Pricing Coalition
25 May 2011
New & experimental hepatitis C treatment

Merck, Roche to Work Together on Hepatitis C Treatments

Editor's pick
San Francisco Chronicle
18 May 2011
New & experimental hepatitis C treatment

Getting Ready; Telaprevir or Boceprevir ?

Editor's pick
HCV New Drugs Research
18 May 2011
New & experimental hepatitis C treatment

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Editor's pick
New York Times
16 May 2011
Hepatitis C symptoms & diagnosis

Age-Based Hep C Screening May Work Better Than Risk-Based Screening

Editor's pick
Internal Medicine News
9 May 2011
New & experimental hepatitis C treatment

Vertex hepatitis C drug gets glowing endorsement

Editor's pick
Reuters
29 April 2011
New & experimental hepatitis C treatment

US FDA panel backs Merck hepatitis drug

Editor's pick
Reuters
28 April 2011
New & experimental hepatitis C treatment

European Gastroenterologists Will Prescribe Telaprevir and Boceprevir to Nonresponder and Treatment-Naive Patients Following Launch, Leading to Higher Treatment Costs Than Interviewed Payers Expect

Editor's pick
Business Wire
19 April 2011
Pharmaceutical industry

Hepatitis C: Greenwich doctor accused of insider trading

Editor's pick
HCV New Drugs Research
14 April 2011
Hepatitis C treatment

New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment

Editor's pick
PR Newswire
12 April 2011
Hepatitis C symptoms & diagnosis

Tackling hepatitis C: a tale of two countries

Editor's pick
The Lancet
11 April 2011
New & experimental hepatitis C treatment

Pegylated Interferon Lambda Boosts Response with Few Side Effects

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Telaprevir Improves HCV Cure Rates Regardless of IL28B Status

Editor's pick
HIVandhepatitis.com
5 April 2011